Point-of-Care Diagnostics Technologies and Market Research Report 2024-2029: Opportunities in Increasing R&D Budgets, AI and ML Integration, Emerging Economies
26 nov. 2024 06h52 HE
|
Research and Markets
Dublin, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The "Point-of-Care Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for...
Global Point of Care Testing Market Research 2024: A $79.3 Billion Industry by 2031, Driven by Technological Innovations and Rising Chronic Disease Prevalence
17 sept. 2024 05h07 HE
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Global Point of Care Testing Market By Diagnostics Segment, By Mode, By Platform, By End User, By Region, Trends, Recent Developments, Company...
Global Point of Care Testing Market Analysis Report 2023: Market to Surpass $75 Billion by 2030 - Technological Advancement in POCT to Spur Market Demand
19 janv. 2024 04h13 HE
|
Research and Markets
Dublin, Jan. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles" report has been added to ...
BioLife Sciences (OTCPK: BLFE) Announces Immediate Commercial Availability of a 10-Minute, Ultra-Rapid, Health Canada Approved, COVID-19 Point of Care Test
26 oct. 2020 08h00 HE
|
BioLife Sciences Inc.
TORONTO, ONTARIO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – With the high demand for Covid-19 testing, BioLife Sciences (OTCPK: BLFE) is pleased to announce the availability of the...
PositiveID Corporation to Present at the LD MICRO “Main Event” Investor Conference on December 6th
27 nov. 2017 08h00 HE
|
PositiveID Corporation
DELRAY BEACH, Fla., Nov. 27, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today...
PositiveID Reports Third Quarter 2017 Results; Revenues increase 38% Year over Year
14 nov. 2017 08h00 HE
|
PositiveID Corporation
DELRAY BEACH, Fla., Nov. 14, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today its financial results for the...
PositiveID’s ExcitePCR Subsidiary Announces FireflyDX-Portable: A Lightweight, Bookbag-sized, Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018
30 août 2017 08h00 HE
|
PositiveID Corporation
DELRAY BEACH, Fla., Aug. 30, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation’s (OTCQB:PSID) ExcitePCR subsidiary today announced the FireflyDX-Portable™, a rechargeable, bookbag-sized, realtime...
PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics Market
25 mai 2017 08h00 HE
|
PositiveID Corporation
DELRAY BEACH, Fla., May 25, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID”) (OTC:PSIDD), a Life Sciences company focused on detection and diagnostics, announced today it has formed a...
PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx System for $19 Billion Global Point-of-Care Diagnostics Market
24 mai 2017 08h30 HE
|
PositiveID Corporation
DELRAY BEACH, Fla., May 24, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID”) (OTC:PSIDD), a Life Sciences company focused on detection and diagnostics, announced today it has formed a...
PositiveID Reports First Quarter 2017 Results
16 mai 2017 08h30 HE
|
PositiveID Corporation
DELRAY BEACH, Fla., May 16, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a Life Sciences company focused on detection and diagnostics, announced today its...